...
首页> 外文期刊>Hepatology: Official Journal of the American Association for the Study of Liver Diseases >The Long Noncoding RNA Cancer Susceptibility 9 and RNA Binding Protein Heterogeneous Nuclear Ribonucleoprotein L Form a Complex and Coregulate Genes Linked to AKT Signaling
【24h】

The Long Noncoding RNA Cancer Susceptibility 9 and RNA Binding Protein Heterogeneous Nuclear Ribonucleoprotein L Form a Complex and Coregulate Genes Linked to AKT Signaling

机译:长的非分量RNA癌敏感性9和RNA结合蛋白质异质核核糖核蛋白L形成与AKT信号传导相关的复合物和核心型基因

获取原文
获取原文并翻译 | 示例
           

摘要

The identification of viability‐associated long noncoding RNAs (lncRNAs) might be a promising rationale for new therapeutic approaches in liver cancer. Here, we applied an RNA interference screening approach in hepatocellular carcinoma (HCC) cell lines to find viability‐associated lncRNAs. Among the multiple identified lncRNAs with a significant impact on HCC cell viability, we selected cancer susceptibility 9 (CASC9) due to the strength of its phenotype, expression, and up‐regulation in HCC versus normal liver. CASC9 regulated viability across multiple HCC cell lines as shown by clustered regularly interspaced short palindromic repeats interference and single small interfering RNA (siRNA)–mediated and siRNA pool–mediated depletion of CASC9. Further, CASC9 depletion caused an increase in apoptosis and a decrease of proliferation. We identified the RNA binding protein heterogeneous nuclear ribonucleoprotein L (HNRNPL) as a CASC9 interacting protein by RNA affinity purification and validated it by native RNA immunoprecipitation. Knockdown of HNRNPL mimicked the loss‐of‐viability phenotype observed upon CASC9 depletion. Analysis of the proteome (stable isotope labeling with amino acids in cell culture) of CASC9‐depleted and HNRNPL‐depleted cells revealed a set of coregulated genes which implied a role of the CASC9:HNRNPL complex in AKT signaling and DNA damage sensing. CASC9 expression levels were elevated in patient‐derived tumor samples compared to normal control tissue and had a significant association with overall survival of HCC patients. In a xenograft chicken chorioallantoic membrane model, we measured decreased tumor size after knockdown of CASC9. Conclusion: Taken together, we provide a comprehensive list of viability‐associated lncRNAs in HCC; we identified the CASC9:HNRNPL complex as a clinically relevant viability‐associated lncRNA/protein complex which affects AKT signaling and DNA damage sensing in HCC.
机译:活力相关的长度非编码RNA(LNCRNA)的鉴定可能是肝癌新治疗方法的有希望的理由。在这里,我们在肝细胞癌(HCC)细胞系中施用RNA干扰筛选方法,以寻找生存率相关的LNCRNA。在具有显着影响HCC细胞活力的多个鉴定的LNCRNA中,由于其表型,表达和HCC与正常肝脏的强度,我们选择了癌症敏感性9(CASC9)。 Casc9跨多个HCC细胞系的受管能力,如聚类规则间隙的短语重复干扰和单个小干扰RNA(siRNA)介导的和siRNA池介导的Casc9的耗尽。此外,Casc9枯竭导致细胞凋亡的增加和增殖降低。我们通过RNA亲和纯化将RNA结合蛋白质异质核核糖核蛋白L(HNRNPL)作为CASC9相互作用,并通过天然RNA免疫沉淀验证。 HNRNPL的敲低模仿在Casc9耗尽时观察到的活力表型。 Casc9耗尽和HNRNPL-耗尽细胞蛋白质组(稳定同位素标记用细胞培养中的氨基酸)揭示了一组暗示Casc9:HNRNPL复合物在AKT信号传导中的作用和DNA损伤感测的核心规模的基因。与正常对照组织相比,患者衍生的肿瘤样品中的Casc9表达水平升高,并与HCC患者的整体存活有显着关系。在异种移植鸡培训型膜模型中,我们在Casc9敲低后测量肿瘤大小降低。结论:携带,我们提供了HCC中的可生存能力相关的LNCRNA清单;我们鉴定了CASC9:HNRNPL复合物作为临床相关的生存能相关的LNCRNA /蛋白质复合物,其影响HCC中的AKT信号传导和DNA损伤感应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号